Marcus D. Goncalves, MD, PhD, has been appointed director of the Holman Division of Endocrinology, Diabetes, and Metabolism at NYU Langone Health.
He succeeds Ira J. Goldberg, MD, who has led the division since 2014 and will continue as a member of the faculty.
Goncalves joined NYU Langone in 2024 from Weill Cornell Medicine and New York-Presbyterian Hospital. He also serves as the Clarissa and Edgar Bronfman, Jr., associate professor of endocrinology and director of Systemic Metabolism Research in the Department of Medicine at NYU Grossman School of Medicine, and as an associate professor in the Department of Radiation Oncology.
A nationally recognized endocrinologist and physician-scientist, he leads a robust research program at the intersection of metabolism, cancer, and endocrine signaling. His work has advanced understanding of conditions including cachexia, obesity, insulin resistance, and the metabolic effects of dietary sugars such as fructose, with a consistent focus on translating discovery into better care for patients.
As director, Goncalves will guide the division’s clinical, research, and training missions.
Endocrine News published a clinical update in Research Highlights on 03 Mar 2026.
The item focuses on Marcus Goncalves Named Director of NYU Langone’s Holman Division of Endocrinology, Diabetes, & Metabolism.
Review the original article for the full source wording and details.